Jennifer Cochran
Director/Board Member at OMNIAB, INC.
Net worth: 495 364 $ as of 29/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Matthew Foehr | M | 51 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
Charles Berkman | M | 55 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
Shelley Force Aldred | M | - |
Rondo Therapeutics, Inc.
Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | 5 years |
John Higgins | M | 54 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
Heath Lukatch | M | 56 |
Red Tree Venture Capital
Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California.
Virsti Therapeutics, Inc.
| 4 years |
Aaron Cravens | M | - |
Revel Pharmaceuticals, Inc.
Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA. | 5 years |
Carolyn Bertozzi | M | 57 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
Paul C Tumeh | M | - |
Biograph 55, Inc.
Biograph 55, Inc. BiotechnologyHealth Technology Biograph 55, Inc. is a biotechnology firm. The CEO of the American company is Paul C Tumeh. | - |
Joshua Tamaroff | M | 38 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
Nathan D. Trinklein | M | - |
Rondo Therapeutics, Inc.
Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | 3 years |
Sarah Boyce | F | 52 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
Todd Pettingill | M | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | - |
Allen Ebens | M | - |
Virsti Therapeutics, Inc.
| - |
Jason Crawford | M | - |
Revel Pharmaceuticals, Inc.
Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA. | 5 years |
David Spiegel | M | - |
Revel Pharmaceuticals, Inc.
Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA. | 5 years |
Tim Schnabel | M | - |
Switch Bioworks, Inc.
Switch Bioworks, Inc. Chemicals: AgriculturalProcess Industries Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation. | 2 years |
Mark Blumenkranz | M | 73 |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | 9 years |
Steven Love | M | 55 | 1 years | |
Amy Chang | F | 47 |
Switch Bioworks, Inc.
Switch Bioworks, Inc. Chemicals: AgriculturalProcess Industries Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation. | 2 years |
Elizabeth Sattely | F | - |
Switch Bioworks, Inc.
Switch Bioworks, Inc. Chemicals: AgriculturalProcess Industries Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation. | 2 years |
Kurt Gustafson | M | 56 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
Jim Swartz | M | - |
Switch Bioworks, Inc.
Switch Bioworks, Inc. Chemicals: AgriculturalProcess Industries Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation. | 2 years |
Marie-Cecile van de Lavoir | M | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | - |
Donna Ventura | F | - | 2 years | |
Jon Edwards | M | - |
Virsti Therapeutics, Inc.
| - |
Debi Watson | F | - |
Rondo Therapeutics, Inc.
Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | 2 years |
Jeremy S. Caldwell | M | 55 |
Red Tree Venture Capital
Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California. | 1 years |
Nina Kjellson | F | 49 |
Rondo Therapeutics, Inc.
Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | - |
Eric Vajda | M | - | - | |
Krishna R. Polu | M | 50 |
Red Tree Venture Capital
Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California. | 3 years |
Patrick Burgermeister | M | 55 |
Revel Pharmaceuticals, Inc.
Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA. | - |
Benjamin Silbert | M | 54 | - | |
Cia McCaffrey | F | - | - | |
Christoper Silvia | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Hesaam Esfandyarpour | M | - |
Stanford University
| 5 years |
Pin Pin Tea-Mankorn | F | - |
Stanford University
| 10 years |
Rod A. Beckstrom | M | - |
Stanford University
| 3 years |
James Dudley | M | - |
Stanford University
| 5 years |
Neel Murthy | M | - |
Stanford University
| 6 years |
Joseph Lau | M | - |
Stanford University
| 4 years |
Lucio Tan | M | 31 |
Stanford University
| 6 years |
Alisha Adam | F | - |
Stanford University
| 5 years |
Brain Banwoong Koo | M | - |
Stanford University
| 2 years |
Haithem Turki | M | - |
Stanford University
| 7 years |
will oberndorf | M | - |
Stanford University
| 14 years |
Artem Trotsyuk | M | - |
Stanford University
| 4 years |
John Henry Styles | M | - |
Stanford University
| 4 years |
Usua U Amanam | M | - |
Stanford University
| 6 years |
Edward Segal | M | - |
Stanford University
| 4 years |
Andrew Summerville | M | - |
Stanford University
| 4 years |
Scott Himmelberger | M | - |
Stanford University
| 5 years |
Greg Kress | M | - |
Stanford University
| 5 years |
Wan-Jin Park | M | 34 |
Stanford University
| 6 years |
Leeor Mushin | M | - |
Stanford University
| 2 years |
Jason Mercer | M | - |
Stanford University
| 2 years |
Amanda McLean | F | - |
Stanford University
| 5 years |
WIlliam Matekar | M | - |
Stanford University
| 6 years |
Forrest White | M | - |
Stanford University
| 5 years |
David McColl | M | - |
Stanford University
| 6 years |
Cody Evans | M | - |
Stanford University
| 2 years |
Alejandro Gandini | M | - |
Stanford University
| 2 years |
Emily Henriksson | F | - |
Stanford University
| 6 years |
Petr Johanes | M | - |
Stanford University
| 12 years |
Vic Miller | M | - |
Stanford University
| 4 years |
Austin Ray | M | - |
Stanford University
| 7 years |
Haomiao Huang | M | - |
Stanford University
| 7 years |
Elaine Zelby | F | - |
Stanford University
| 5 years |
Peter Moran | M | - |
Stanford University
| 4 years |
Zavain Dar | M | 35 |
Stanford University
| 6 years |
Hugh Browne | M | - |
Stanford University
| 2 years |
Curtis Spencer | M | - |
Stanford University
| - |
John Komkov | M | - |
Stanford University
| 10 years |
James P. McGillicuddy | M | - |
Stanford University
| 5 years |
Michael Paulus | M | - |
Stanford University
| 5 years |
Nick Noone | M | - |
Stanford University
| 4 years |
Kunal Ghosh | M | - |
Stanford University
| 5 years |
Dmitry Pushkarev | M | - |
Stanford University
| 5 years |
Samir Siddhanti | M | - |
Stanford University
| 5 years |
Stewart Lynn | M | - |
Stanford University
| 5 years |
Mada Seghete | F | - |
Stanford University
| 8 years |
John Melas-Kyriazi | M | - |
Stanford University
| 4 years |
Chase Beeler | M | - |
Stanford University
| 5 years |
Steven Hong | M | - |
Stanford University
| 3 years |
Kai Sun | M | 38 |
Stanford University
| 5 years |
Iveshu Bhatia | M | - |
Stanford University
| 1 years |
Geoffrey Woo | M | - |
Stanford University
| 4 years |
Sahil Bloom | M | - |
Stanford University
| 4 years |
Michael Wert | M | - |
Stanford University
| 2 years |
Joel Dudley | M | - |
Stanford University
| 4 years |
Looi Qin En | M | - |
Stanford University
| 5 years |
Nathan Nolop | M | - |
Stanford University
| 11 years |
Adam Klotz | M | - |
Stanford University
| 10 years |
Clancey Stahr | M | - |
Stanford University
| 4 years |
Etosha Cave | M | - |
Stanford University
| 8 years |
Kathy Hannun | F | - |
Stanford University
| 10 years |
Xuefeng Koh | M | - |
Stanford University
| 5 years |
Ben Daniel | M | - |
Stanford University
| 1 years |
Djalil Reghis | M | - |
Stanford University
| 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 98 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jennifer Cochran
- Personal Network